Page 167 - Glucose Monitoring Devices

168 CHAPTER 8 Accuracy of CGM systems

References
[1] Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes
Technology and Therapeutics 2000;2(Suppl. 1). S-13 e S-18.
[2] Bode BW. Clinical utility of the continuous glucose monitoring system. Diabetes T-
echnology and Therapeutics 2000;2(Suppl. 1). S-35 e S-42.
[3] Feldman B, Brazg R, Schwartz S, Weinstein R. A continuous glucose sensor based on
wired enzyme technology e results from a 3-day trial in patients with type 1 diabetes.
Diabetes Technology and Therapeutics 2003;5:769e78.
[4] Deiss D, Bolinder J, Riveline J, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M.
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-
time continuous glucose monitoring. Diabetes Care 2006;29:2730e2.
[5] Garg K, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in
glycemic excursions with a transcutaneous, real-time continuous glucose sensor. Dia-
betes Care 2006;29:44e50.
[6] Kovatchev BP, Clarke WL. Continuous glucose monitoring reduces risks for hypo- and
hyperglycemia and glucose variability in diabetes. Diabetes 2007;56(Suppl. 1):0086OR.
[7] The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study
Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
New England Journal of Medicine 2008;359:1464e76.
[8] Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes
therapy. Diabetes Care 2005;28:1231e9.
[9] Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL,
Peters A, Wolpert H. Clinical application of emerging sensor technologies in diabetes
management: consensus guidelines for continuous glucose monitoring. Diabetes Tech-
nology and Therapeutics 2008;10:232e46.
[10] Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabetic Medi-
cine 2006;23:1e12.
[11] Klonoff DC. The artificial pancreas: how sweet engineering will solve bitter problems.
Journal of Diabetes Science and Technology 2007;1:72e81.
[12] Clarke WL, Kovatchev BP. The artificial pancreas: how close we are to closing the loop?
Pediatric Endocrinology Reviews 2007;4:314e6. PMID: 17643078.
[13] Cobelli C, Renard E, Kovatchev BP. Perspectives in diabetes: artificial pancreas: past,
present, future. Diabetes 2011;60:2672e82. PMID: 22025773; PMCID: PMC3198099.
[14] Kovatchev BP. Diabetes technology: monitoring, analytics, and optimal control. Cold
Spring Harbor Perspectives in Medicine 2018. https://doi.org/10.1101/cshper-
spect.a034389. PMID: 30126835.
[15] Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts
plasma glucose independent of insulin: implications for continuous monitoring. Amer-
ican Journal of Physiology Endocrinology and Metabolism 1999;277:E561e71.
[16] Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose
measurements? Diabetes Technology and Therapeutics 2000;2:461e72.
[17] Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF. Interstitial
fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia 2005;48:
1833e40.